Table 1.

Baseline characteristics of MDS patients

Subtype	MDS
	SLD	MLD	RS-SLD	RS-MLD	MDS-5q-	EB-1	EB-2
	n = 9	n = 9	n = 23	n = 7	n = 3	n = 21	n = 26
Age (Year)	62	53	62	68	68	65	55
	47–82	20–69	34–84	40–84	57–83	30–82	33–82
Male/Female	7:2	5:4	14:9	4:3	1:2	12:9	16:10
Blast (%)	0.5	0	0.5	0.5	0	8	16.5
	0–4	0–4	0–4.5	0–4.5	0–1	5.5–9.5	10.5–19.5
HGB (g/L)	108	77	74	87	79	72	76
	70–149	57–149	38–138	61–120	69–126	42–129	53–145
PLT × 10^9/L	92	40	122	52	114	82	49
	11–591	9–189	3–428	8–503	51–210	3–295	6–323
ANC × 10^9/L	1.34	1.58	2.23	0.85	1.84	1.16	0.9
	(0.73–6.12)	(0.21–10.70)	(0.26–8.97)	(0.56–3.84)	(0.94–2.44)	(0.11–6.50)	(0.09–6.99)

MDS myelodysplastic syndrome, RS ring sideroblasts, SLD single lineage dysplasia, MLD multilineage dysplasia, EB1 excess blasts type 1, EB2 excess blasts type 2, HGB hemoglobin, PLT platelet, ANC absolute neutrophil count